Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.854
+0.01
(+1.67%)
After-Hours: 20:00
Sunshine Biopharma Free Cash Flow: -9.563M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.563M |
| September 30, 2023 | -8.816M |
| June 30, 2023 | -9.471M |
| March 31, 2023 | -5.973M |
| December 31, 2022 | -5.248M |
| September 30, 2022 | -3.314M |
| June 30, 2022 | -2.791M |
| March 31, 2022 | -2.836M |
| December 31, 2021 | -1.829M |
| September 30, 2021 | -1.941M |
| June 30, 2021 | -1.462M |
| March 31, 2021 | -0.9248M |
| December 31, 2020 | -0.6585M |
| September 30, 2020 | -0.3631M |
| June 30, 2020 | -0.3278M |
| March 31, 2020 | -0.2937M |
| December 31, 2019 | -0.4967M |
| September 30, 2019 | -0.4755M |
| June 30, 2019 | -0.5653M |
| March 31, 2019 | -0.5924M |
| December 31, 2018 | -0.5317M |
| September 30, 2018 | -0.6373M |
| June 30, 2018 | -0.5873M |
| March 31, 2018 | -0.6124M |
| December 31, 2017 | -0.5472M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3663M |
| June 30, 2017 | -0.3034M |
| March 31, 2017 | -0.3441M |
| December 31, 2016 | -0.3142M |
| September 30, 2016 | -0.6258M |
| June 30, 2016 | -0.6654M |
| March 31, 2016 | -0.8362M |
| December 31, 2015 | -0.8676M |
| September 30, 2015 | -0.7726M |
| June 30, 2015 | -0.688M |
| March 31, 2015 | -0.5608M |
| December 31, 2014 | -0.5386M |
| September 30, 2014 | -0.3306M |
| June 30, 2014 | -0.3982M |
| March 31, 2014 | -0.3155M |
| December 31, 2013 | -0.5644M |
| September 30, 2013 | -0.6974M |
| June 30, 2013 | -0.7721M |
| March 31, 2013 | -0.698M |
| December 31, 2012 | -0.3931M |
| September 30, 2012 | -0.3381M |
| June 30, 2012 | -0.2961M |
| March 31, 2012 | -0.2877M |
| December 31, 2011 | -0.2973M |
| September 30, 2011 | -0.4239M |
Free Cash Flow Range, Past 5 Years
-9.563M
Minimum
Dec 2023
-0.2937M
Maximum
Mar 2020
-3.018M
Average
-1.829M
Median
Dec 2021
Free Cash Flow Benchmarks
| Lexaria Bioscience Corp | -5.408M |
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -34.18M |
| Edesa Biotech Inc | -6.252M |
| Xenon Pharmaceuticals Inc | -150.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.690M |
| Cash from Investing (Quarterly) | -0.2692M |
| Cash from Financing (Quarterly) | -0.0305M |
| Free Cash Flow Per Share (Quarterly) | -12.57 |
| Free Cash Flow to Equity (Quarterly) | -2.993M |
| Free Cash Flow to Firm (Quarterly) | -2.993M |
| Free Cash Flow Yield | -4.70K% |